Yes — lifelong supplementation is recommended after most bariatric procedures.

Because your body adapts to calorie restriction by slowing metabolism and increasing hunger. This is metabolic adaptation, and it happens to almost everyone.

Cutting calories increases ghrelin — your hunger hormone. This makes dieting feel harder the longer you do it.

Yes. Weight regain is a predictable biological response. Your body increases hunger and decreases metabolism to push you back to your old weight.

Your set point is the weight range your body defends. When you diet, your body fights to return to that range through hormonal and metabolic changes.

No. Willpower cannot override biology. Hormones and metabolism are stronger than motivation.

Surgery changes the hormones that control hunger and metabolism. It lowers the defended set point and stops the body from fighting weight loss.

No. Surgery treats the biology that diets cannot. It is a medical treatment for a medical condition.

Yes — but not through dieting alone. Surgery and medical therapy can reset hormonal signals and improve metabolic function.

Genetics, hormones, metabolism, and setpoint differences play major roles. It’s not about effort — it’s about biology.

If you’ve struggled with weight despite repeated attempts, or if you have obesityrelated health conditions, you may be a candidate. A consultation can determine the best approach.

It’s not age — it’s body composition.
Years of dieting cause muscle loss.
Regain comes back as fat.
More fat + less muscle = lower BMR.

Yes.
Every diet lowers muscle mass.
Every regain increases fat mass.
This shifts your body composition and lowers your metabolic rate.

Because your BMR is lower than it used to be.
The same deficit that worked at 25 doesn’t work at 45 if you’ve lost muscle.

Yes — but it requires:

• adequate protein
• resistance training
• avoiding extreme calorie restriction
• stabilizing hunger hormones
• improving body composition

No.
You can still lose muscle after surgery.
But surgery reduces hunger and cravings, which helps patients avoid the extreme restriction that causes the worst muscle loss.

Because your BMR is lower.
Your body burns fewer calories at rest, so regain happens more quickly.

No — it’s adapted.
Your body is responding to years of underfueling and weight cycling.

Surgery:

• reduces hunger
• improves hormonal signals
• lowers the defended set point
• reduces the metabolic “fight back”
• helps stabilize intake
• stops the cycle of chronic dieting

It treats the biology that diets can’t.

Bariatric surgery works because it changes hunger, fullness, blood sugar, and metabolism hormones — not because the stomach is smaller. After surgery, GLP‑1 and PYY surge, slowing digestion, increasing fullness, and stabilizing blood sugar. Ghrelin, the hunger hormone, drops significantly. Insulin sensitivity improves within days, and bile acids shift toward a healthier metabolic profile. These hormonal changes make long‑term weight loss possible in ways dieting never could.

Cravings decrease because bariatric surgery rewires the gut–brain axis. After surgery, GLP‑1 and PYY rise sharply, calming hunger signals and reducing reward‑driven eating. Ghrelin levels fall, so intrusive hunger quiets. Dopamine and food‑reward pathways also change, meaning food no longer triggers the same urgency or “food noise.” Patients often describe this as the first time they feel “in control” around food.

GLP‑1 is a powerful incretin hormone that controls hunger, fullness, blood sugar, and digestion. It slows gastric emptying, reduces appetite, improves insulin secretion, and stabilizes blood sugar. After bariatric surgery, GLP‑1 levels increase 2–5×, which is why patients feel fuller, have fewer cravings, and often see diabetes improve rapidly. GLP‑1 medications like Ozempic and Wegovy mimic this same hormone.

Diabetes improves quickly because bariatric surgery triggers an immediate rise in GLP‑1 and PYY, which enhance insulin secretion and reduce insulin resistance. These hormonal shifts happen within hours to days — long before significant weight loss occurs. This is known as the incretin effect, and it’s why many patients see dramatic improvements in blood sugar and may even discontinue diabetes medications shortly after surgery.

Obesity is considered a chronic disease because it is driven by long‑term biological changes — not short‑term behavior. Hormones like ghrelin, leptin, insulin, GLP‑1, and PYY regulate hunger, fullness, metabolism, and fat storage. When these systems become dysregulated, the body defends a higher weight set‑point and resists weight loss. Obesity also progresses over time, increases the risk of more than 250 diseases, and requires ongoing medical treatment, just like diabetes or hypertension.

Untreated obesity significantly increases the risk of heart disease, stroke, type 2 diabetes, sleep apnea, fatty liver disease, kidney disease, infertility, and more than 13 obesity‑related cancers. It also accelerates organ damage, worsens inflammation, and shortens lifespan. Even modest, sustained weight loss — 5%, 10%, or 25% with bariatric surgery — dramatically reduces these risks and improves long‑term health outcomes.

Body composition — the balance of fat mass and lean muscle — is far more important than weight alone. High body fat percentage increases inflammation, insulin resistance, metabolic disease, and cardiovascular risk, even in people who are “normal weight.” Increasing lean muscle improves metabolism, stabilizes blood sugar, protects joints, and raises basal metabolic rate. This is why percent body fat and muscle mass matter more than the number on the scale.

Diets fail because they fight biology, not behavior. When you restrict calories, ghrelin rises, hunger increases, fullness hormones drop, and metabolism slows — a survival response called metabolic adaptation. The body defends its weight set‑point, making long‑term weight loss extremely difficult. This is why 95% of diets fail and why medical therapy or metabolic surgery is often needed to change the underlying hormonal drivers of weight regain.

Choosing the right bariatric surgery depends on your anatomy, metabolic health, reflux symptoms, diabetes severity, BMI, and long‑term goals.Sleeve gastrectomy is effective and simpler, ideal for patients without severe reflux or advanced diabetes.Gastric bypass is best for patients with significant reflux, strong metabolic disease, or diabetes needing more powerful hormonal change.Duodenal switch provides the greatest weight‑loss and metabolic impact, especially for patients with very high BMI or severe insulin resistance.Each procedure has unique strengths — the right choice comes from matching your biology and medical needs with the operation that delivers the safest, most durable results.

Bariatric surgery works because it changes hunger, fullness, blood sugar, and metabolism hormones — not because the stomach is smaller. After surgery, GLP‑1 and PYY surge, slowing digestion, increasing fullness, and stabilizing blood sugar. Ghrelin, the hunger hormone, drops significantly. Insulin sensitivity improves within days, and bile acids shift toward a healthier metabolic profile. These hormonal changes make long‑term weight loss possible in ways dieting never could.

Obesity treatment falls into three evidence‑based categories:Lifestyle therapy, which improves nutrition, activity, sleep, and behavior but rarely overcomes the hormonal drivers of obesity;Medical therapy, including FDA‑approved medications like GLP‑1 agonists that target hunger, cravings, insulin resistance, and metabolic adaptation;and endoscopic or surgical therapy, which creates the most powerful and durable metabolic change by reprogramming hunger hormones, improving insulin sensitivity, and lowering long‑term disease risk.The right treatment depends on your biology, metabolic health, BMI, diabetes severity, reflux, and long‑term goals. Most patients benefit from a combination of therapies — and many require metabolic surgery to treat the underlying disease, not just the symptoms.

Bariatric surgery works because it changes hunger, fullness, blood sugar, and metabolism hormones — not because the stomach is smaller. After surgery, GLP‑1 and PYY surge, slowing digestion, increasing fullness, and stabilizing blood sugar. Ghrelin, the hunger hormone, drops significantly. Insulin sensitivity improves within days, and bile acids shift toward a healthier metabolic profile. These hormonal changes make long‑term weight loss possible in ways dieting never could.

GLP‑1 is a powerful incretin hormone that controls hunger, fullness, blood sugar, and digestion. It slows gastric emptying, reduces appetite, improves insulin secretion, and stabilizes blood sugar. After bariatric surgery, GLP‑1 levels increase 2–5×, which is why patients feel fuller, have fewer cravings, and often see diabetes improve rapidly. GLP‑1 medications like semaglutide and tirzepatide mimic this same hormone.

ESG is a non-surgical weight-loss procedure that uses an endoscopic suturing device to reduce stomach volume without incisions.

Most patients lose 15–20% of total body weight within 12 months.

Yes. ESG can be reversed or revised endoscopically if needed.

No. ESG is typically performed as an outpatient procedure.

Most insurance plans do not cover ESG; it is often self-pay.

Balloon removal is performed endoscopically under sedation and typically takes less than 20 minutes.

No. Removal is generally well tolerated with minimal discomfort.

Yes. Many patients undergo repeat balloon therapy if medically appropriate.

Yes. Patients typically fast for 8 hours before the procedure.

Insurance coverage varies; removal may be covered if medically necessary.

EGD is a diagnostic procedure that uses a flexible camera to examine the esophagus, stomach, and duodenum.

EGD is used to evaluate reflux, ulcers, strictures, bleeding, bariatric anatomy, or postoperative symptoms.

No. EGD is performed under sedation and is generally painless.

Most EGDs take 10–15 minutes.

Yes. EGD is typically covered when medically indicated.

Stents are placed endoscopically to treat leaks, strictures, or obstructions in the gastrointestinal tract.

Patients may experience temporary discomfort or chest pressure.

Stents typically remain for 4–8 weeks depending on the condition.

Stents are used for leaks, fistulas, strictures, and postoperative complications.

Dilation widens narrowed areas of the esophagus, stomach, or anastomosis using balloons or dilators.

Yes. Stent placement is typically covered when medically necessary.

Strictures may result from surgery, inflammation, scarring, or ulcers.

Some patients require multiple sessions depending on severity.

No. Dilation is performed under sedation and is generally painless.

Yes. Dilation is typically covered when medically indicated.

Fistula closure uses clips, sutures, or sealants to close abnormal connections between GI structures.

Yes. Many fistulas close successfully with endoscopic therapy.

Fistulas may occur after surgery, inflammation, or infection.

No. It is performed endoscopically without incisions.

Yes. Coverage is common when medically necessary.

Endoscopic revision tightens or reshapes bariatric anatomy without surgery to improve restriction and weight loss.

Patients with weight regain or dilated anatomy after sleeve or bypass may qualify.

Most patients lose 10–20% of total body weight.

No. It is incisionless and performed through the mouth.

Insurance coverage varies; many plans consider it self-pay.

Endoscopy evaluates the size, type, and severity of a hiatal hernia and its impact on reflux or bariatric anatomy.

It guides treatment decisions for GERD, sleeve reflux, and surgical planning.

Yes. Endoscopy provides direct visualization of the esophageal hiatus and stomach position.

No. It is performed under sedation and is painless.

Yes. It is typically covered when medically indicated.

A hiatal hernia occurs when part of the stomach moves into the chest through the diaphragm. Paraesophageal hernias are larger and can cause serious symptoms.

Symptoms include reflux, chest pain, regurgitation, difficulty swallowing, and shortness of breath.

Repair involves returning the stomach to the abdomen, closing the diaphragm opening, and often reinforcing it with mesh.

Yes. Most repairs are performed laparoscopically or robotically.

Yes. Hiatal hernia repair is typically covered when medically indicated.

Anti-reflux surgery restores the barrier between the stomach and esophagus using fundoplication or the LINX magnetic device.

Fundoplication wraps the upper stomach around the esophagus to prevent reflux.

Patients with chronic GERD, regurgitation, or medication-resistant symptoms may qualify.

LINX uses a ring of magnetic beads to strengthen the lower esophageal sphincter while preserving normal swallowing.

Yes. Most insurance plans cover fundoplication and LINX when medically necessary.

Reasons include persistent reflux, slipped fundoplication, recurrent hiatal hernia, or complications.

Foregut revision corrects issues from prior esophageal or stomach surgery, including failed reflux surgery or recurrent hernias.

Yes. Revision requires advanced expertise due to scar tissue and altered anatomy.

Options include redo fundoplication, conversion to LINX, or hernia re-repair.

Yes. Most plans cover revision when medically necessary.

An esophageal diverticulum is a pouch that forms in the esophagus, causing swallowing issues or regurgitation.

Symptoms include dysphagia, regurgitation, coughing, and aspiration.

Treatment may involve surgical removal or endoscopic therapy depending on size and location.

Yes. Many diverticula can be treated endoscopically or robotically.

Yes. Coverage is common when medically indicated.

Motility disorders affect how the esophagus contracts, causing swallowing difficulty or chest pain.

Diagnosis involves endoscopy, manometry, and imaging studies.